Dr. Saakshi Khattri
Claim this profileIcahn School of Medicine at Mount Sinai
Studies Pyoderma Gangrenosum
Studies Pyoderma
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
Clinical Trials Saakshi Khattri is currently running
Spesolimab
for Pyoderma Gangrenosum
This trial is testing spesolimab, a medicine that blocks inflammation signals, in patients with severe skin ulcers caused by pyoderma gangrenosum. These patients often suffer from pain and have no standard treatment options. Spesolimab aims to reduce inflammation and help heal their skin ulcers.
Recruiting1 award Phase 28 criteria
TAK-279
for Psoriasis
The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoriasis. All participants will be assigned to study treatments of TAK-279 and will be treated with TAK-279 if the participants meet the study rules. Participants will be in the study for up to 217 weeks, including up to 35 days for the screening period, 52 weeks (Part A) up to 156 additional weeks (Part B) study treatment and 4 weeks follow up period. During the study, participants will visit their study clinic multiple times.
Recruiting2 awards Phase 31 criteria
More about Saakshi Khattri
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Saakshi Khattri has experience with
- Spesolimab
- TAK-279
Breakdown of trials Saakshi Khattri has run
Pyoderma Gangrenosum
Plaque Psoriasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Saakshi Khattri specialize in?
Saakshi Khattri focuses on Pyoderma Gangrenosum and Pyoderma. In particular, much of their work with Pyoderma Gangrenosum has involved treating patients, or patients who are undergoing treatment.
Is Saakshi Khattri currently recruiting for clinical trials?
Yes, Saakshi Khattri is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Saakshi Khattri has studied deeply?
Yes, Saakshi Khattri has studied treatments such as Spesolimab, TAK-279.
What is the best way to schedule an appointment with Saakshi Khattri?
Apply for one of the trials that Saakshi Khattri is conducting.
What is the office address of Saakshi Khattri?
The office of Saakshi Khattri is located at: Icahn School of Medicine at Mount Sinai, New York, New York 10029 United States. This is the address for their practice at the Icahn School of Medicine at Mount Sinai.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.